Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 2, 2016
[Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world]
Y L Wan, Y Wang, B C Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
September 22, 2024
[The efficacy and safety of ibrutinib in the treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia]
Y S Huang, W J Xiong, J J Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 7, 2021
[Central nervous system toxicity caused by bortezomib: five case reports and a review of literature]
J H Liu, H S Fan, S H Deng, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 26, 2010
Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience
P Zhang, E-L Jiang, D-L Yang, et al.
Bone Marrow Transplantation
|
December 20, 2011
An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China
J Huang, D-H Zou, Z-J Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
September 25, 2023
[Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma]
D D Shan, H M Liu, W Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 28, 2017
[Long-term follow-up of multiple myeloma after autologous hematopoietic stem cell transplantation: a single center results]
W W Sui, D H Zou, G An, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
August 12, 2021
[Analysis of the clinical characteristics and prognosis of 20 patients with multicenter Castleman disease]
H S Fan, W W Yan, J Y Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 20, 2022
[Distinguish immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Chinese patients with chronic lymphocytic leukemia]
H Li, T Y Wang, Y Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
August 15, 2022
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component]
Z J Lin, J Zha, S H Yi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 2, 2016
[Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world]
Y L Wan, Y Wang, B C Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
September 22, 2024
[The efficacy and safety of ibrutinib in the treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia]
Y S Huang, W J Xiong, J J Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 7, 2021
[Central nervous system toxicity caused by bortezomib: five case reports and a review of literature]
J H Liu, H S Fan, S H Deng, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 26, 2010
Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience
P Zhang, E-L Jiang, D-L Yang, et al.
Bone Marrow Transplantation
|
December 20, 2011
An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China
J Huang, D-H Zou, Z-J Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
September 25, 2023
[Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma]
D D Shan, H M Liu, W Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 28, 2017
[Long-term follow-up of multiple myeloma after autologous hematopoietic stem cell transplantation: a single center results]
W W Sui, D H Zou, G An, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
August 12, 2021
[Analysis of the clinical characteristics and prognosis of 20 patients with multicenter Castleman disease]
H S Fan, W W Yan, J Y Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 20, 2022
[Distinguish immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Chinese patients with chronic lymphocytic leukemia]
H Li, T Y Wang, Y Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
August 15, 2022
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component]
Z J Lin, J Zha, S H Yi, et al.
Page
of 7